Retaglutide is a innovative GLP-1 receptor agonist currently under study for the treatment of type 2 diabetes. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://junaidjnjy496644.onzeblog.com/39134551/trelaglutide-exploring-a-new-treatment-for-chronic-diseases